Lawrence R Smith

Title: Innovations by Lawrence R Smith in Multiple Sclerosis Vaccination

Introduction

Lawrence R Smith is an accomplished inventor based in Cardiff, CA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines aimed at combating multiple sclerosis. His innovative approach focuses on the pathogenic responses of specific T cell populations.

Latest Patents

Smith holds a patent for a groundbreaking invention titled "Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations." This patent outlines a method for vaccinating mammals to prevent or control T cell-mediated pathologies. The vaccine comprises a T cell receptor (TCR) or a fragment thereof, which corresponds to TCRs present on the surface of T cells that mediate the pathology. The invention aims to induce an immunologically effective response to affect the course of the disease. Notably, it identifies specific β-chain variable regions of the T cell receptor, which are central to the pathogenesis of multiple sclerosis.

Career Highlights

Smith is associated with The Immune Response Corporation, where he continues to work on innovative solutions in immunology. His research has the potential to change the landscape of treatment for multiple sclerosis, providing hope for many affected individuals.

Collaborations

Some of his notable coworkers include Steven W Brostoff and Darcy B Wilson, who have collaborated with him on various projects related to immunology and vaccine development.

Conclusion

Lawrence R Smith's contributions to the field of immunology, particularly through his patent on multiple sclerosis vaccination, highlight his role as an innovative inventor. His work continues to pave the way for advancements in medical treatments.